Drugmaker Bristol-Myers Squibb Co. is cutting jobs again, this time eliminating about 3 percent of its positions in its latest effort to streamline operations.
Amgen Inc. is recalling some lots of its blockbuster Epogen and Procrit anemia treatments because the injected drugs may contain glass flakes that could cause blood clots, swelling of veins, immune system reactions and other problems.
Merck KGaA announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a negative opinion regarding the marketing authorization application for Cladribine Tablets as a treatment for multiple sclerosis.
Bristol-Myers Squibb and AstraZeneca announced results from Phase 3 study showing that dapagliflozin was non-inferior compared to glipizide in improving HbA1c when added to existing metformin therapy during a 52-week treatment period.
Standard operating procedures are a necessary evil. Although cumbersome and at times seeming to hinder more than they help, they have enabled the pharmaceutical industry to grow to the size it is today.
RTS Life Science, a worldwide supplier of automated sample management and pharmaceutical testing systems, has announced the formation of a Pharmaceutical Testing Group.
Lumenera Corporation, a leading manufacturer and developer of high performance digital cameras and custom imaging solutions, has announced INFINITY camera integration with Media Cybernetics Image-Pro software.
JEOL offers the InTouchScope, an analytical, low vacuum scanning electron microscope featuring integrated energy dispersive spectroscopy with the latest silicon drift detector technology.
RXi Pharmaceuticals Corporation, a leader in RNAi-based therapeutics, and EyeGate Pharma, the leader in non-invasive ocular drug delivery announced that they will collaborate on the ocular delivery of RNAi therapeutics.
Ghent University, the University of Antwerp, and BioTools Europe Ltd have announced the creation of the European Centre for Chirality. EC2 brings together leading authorities dedicated to advancing the understanding the role chirality plays in biological processes.
Thousands of older Americans who need new heart valves but are too frail to survive the surgery might soon get a chance at an easier option - a way to thread in an artificial aortic valve without cracking their chests.
A report says treatment has improved substantially at U.S. hospitals for several ailments including heart attacks, pneumonia and children's asthma.
Abbott and Reata Pharmaceuticals announced that they have entered into a collaboration agreement to develop and commercialize bardoxolone methyl, which is currently in late Phase 2 trials for the treatment of chronic kidney disease.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced the presentation of preclinical research describing the mechanism of action of otelixizumab.
European health regulators have banned sales of the once-blockbuster diabetes drug Avandia because of evidence it raises the risk of heart attack, but doctors in the U.S. will be able to continue prescribing it with some significant restrictions.